Medviso AB

Lund, Sweden All Sweden companies → — Founded 2007

Imaging AI Specialist Specialty-Focused AI

Neurosurgery Plastic Surgery Radiology

Radiology & Imaging AI Surgical AI

Bootstrapped / Unfunded

Claim this company

About Medviso AB

Medviso AB is a medical technology company specializing in advanced software solutions for medical imaging analysis and workflow optimization, with a strong emphasis on cardiovascular image analysis and 3D modeling applications. Their mission is to bridge the gap between cutting-edge research and clinical routine, empowering healthcare professionals and researchers alike. The company’s clinical software portfolio includes Segment CMR, designed for quantitative analysis of cardiac magnetic resonance images, and Segment 3DPrint, which facilitates the seamless conversion of DICOM images into high-quality, ready-to-print 3D models for diagnostic purposes, visualization, measurement, and treatment planning in various fields including orthopedic, maxillofacial, and cardiovascular applications.

Medviso actively integrates artificial intelligence into its offerings to streamline clinical workflows. For instance, they are developing AI algorithms to fully automate flow and infarct quantification in cardiac MRI exams, aiming to significantly reduce analysis time and free up resources for patient care. Beyond their clinical products, Medviso supports the research community by providing their software, Segment, freely for research purposes, which is utilized by research groups in over 75 countries worldwide for MRI, CT, and Myocardial perfusion SPECT image analysis. The company has achieved FDA 510(k) clearance and CE-marking for three of its software solutions, demonstrating their commitment to regulatory compliance and product quality.

Medviso also offers a range of medical services, including 3D modeling and 3D printed models from CT or MR images, regulatory consulting for medical software products seeking CE-marking and/or FDA 510(k) application, and custom development of advanced imaging solutions and algorithms for OEM partners. Their expertise extends to developing algorithms for analysis across various organs using MR, CT, SPECT, and PET imaging modalities.

Focus Areas

medical image analysis cardiovascular MRI cardiac CT myocardial perfusion SPECT 3D modeling AI-powered diagnostics strain analysis cardiac function analysis medical software development

Business Intelligence

Technology

MATLAB-based algorithms, cloud-native (implied by web-based image transfer and automated processing), AI operating system (AI AutoMate for automated processing)

What Physicians Need to Know

Medical Imaging Analysis

Medviso AB specializes in comprehensive quantitative analysis of cardiac magnetic resonance (CMR) and cardiac computed tomography (CT) images. Their software, such as Segment CMR and Segment CT Research, provides tools for detailed assessment of cardiac function, volumes (LV, RV, LA, RA), flow (2D and 4D), viability, and tissue characterization (T1/T2/T2*/ECV quantification). They also offer analysis for myocardial perfusion SPECT images.

Workflow Optimization

The company focuses on streamlining clinical and research workflows through features like AI AutoMate for automation, seamless clinic-research solutions, and batch export scripts. Their user-friendly interfaces and efficient software development platform ensure quick turnaround times for updates, enhancing daily operational efficiency for healthcare professionals.

Cardiovascular Image Analysis

A core specialization is advanced cardiovascular image analysis, encompassing a broad range of tools for cardiac MRI and CT. This includes detailed analysis of all heart chambers, myocardial strain analysis (both feature tracking and tagging), and specialized modules for various cardiac pathologies and functional assessments.

3D Modeling & 3D Printing

Medviso provides solutions for 3D modeling and 3D printing, notably with Segment 3DPrint, which facilitates a seamless transition from DICOM images to high-quality, ready-to-print 3D models. They also offer a 3D Modelling Service and a Quality Management System (QMS Point-of-Care) for point-of-care 3D printed devices.

AI Algorithms

The company integrates advanced AI algorithms for automatic and semi-automatic segmentation of cardiac structures (LV, RV, LA, RA) in both MR and CT images. These deep learning methods aim to provide fast, reliable, and reproducible segmentations, significantly reducing manual effort and analysis time.

Medical Software Solutions

Medviso develops a portfolio of medical software solutions, including Segment CMR for clinical cardiac MR analysis, Segment 3DPrint for 3D modeling, and Segment CT Research for cardiac CT analysis. They also offer Segment Research (freely available for research), Segment Pre-clinical, a Strain analysis module, and custom development services.

Regulatory Consulting

With over 10 years of experience, Medviso AB offers regulatory consulting services, specializing in the framework for medical image analysis software. They assist companies in achieving CE-marking and FDA 510(k) clearance, providing comprehensive support from initial idea to regulatory application.

Strain Analysis

Medviso's Strain analysis module is a clinically approved software solution for cardiac strain analysis, recognized for having the highest reproducibility on the market. It uniquely includes both feature tracking and tagging analysis in one package, applicable to both short-axis and long-axis images.

Physician Tip

For physicians, Medviso AB's solutions offer significant advantages by providing highly reproducible and validated quantitative analysis of cardiac MR and CT images. The integration of AI algorithms in products like Segment CMR and Segment CT Research automates complex segmentation tasks, drastically reducing analysis time and allowing for a quicker diagnostic turnaround. The unique combination of feature tracking and tagging in their strain analysis module provides comprehensive insights into myocardial function. Furthermore, their FDA-cleared and CE-marked software ensures regulatory compliance and reliability for clinical decision-making. The ability to generate high-quality 3D models from imaging data can also be invaluable for surgical planning, patient education, and interventional guidance. The company's commitment to translating cutting-edge research into clinical tools means physicians benefit from state-of-the-art analysis methods developed in close collaboration with leading academic institutions.

Medviso's software solutions are designed to be compatible with DICOM images, a standard in medical imaging. Their products, such as Segment CMR and Segment CT Research, offer PACS connectivity for efficient import of images and embedded patient databases. The complete software packages can include PACS integration, report generation modules, and patient database synchronization modules. They also offer custom development for advanced imaging solutions and algorithms to OEM partners, indicating flexibility for integration into existing healthcare IT infrastructures.

Products by Medviso AB

No products listed for this company yet. Know of one? Suggest it →

Reviews & Opinions

No web reviews on file yet for Medviso AB. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Medviso AB.

Loading videos...

Videos load interactively. If none appear, search YouTube for Medviso AB →

View all on YouTube

Press & Coverage

Medviso News

Segment CMR 4.3.1 release

Medviso announced the release of Segment CMR version 4.3.1, introducing AI-based flow vessel segmentation, new scar quantification tools, and relaxometry improvements for clinical cardiac MR use.

2026-08

Medviso News

Segment 4.3

Medviso released Segment version 4.3, featuring new AI algorithms, 4D flow analysis capabilities, and various workflow and reporting enhancements.

2026-03

MathWorks

Medviso Receives FDA 510(k) Approval and CE Marking for Cardiovascular Analysis Software

Medviso's software, developed in MATLAB, received FDA 510(k) approval in the U.S. and CE marking in Europe, enabling the company to offer standalone production software to clinicians.

unknown

FDA

510(k) Premarket Notification - Segment 3DPrint

The FDA granted 510(k) clearance for Medviso's Segment 3DPrint, a software for reviewing and segmenting medical images to generate 3D models for diagnostic and treatment planning purposes.

2022-05

FDA

510(k) Premarket Notification - Segment CMR

The FDA granted 510(k) clearance for Medviso's Segment CMR, a software for quantitative cardiac magnetic resonance analysis.

2017-04

FDA

510(k) Premarket Notification - Segment

The FDA granted 510(k) clearance for Medviso's Segment, a cardiovascular image analysis software.

2010-05

Journal of Cardiovascular Magnetic Resonance

Segment: a freely available software for cardiovascular image analysis

This article describes Segment, a comprehensive software tool for cardiovascular image analysis developed in collaboration with Lund Cardiac MR Group, highlighting its features and research applications.

2010-01

Frequently Asked Questions

What are Medviso AB's primary software solutions for cardiovascular imaging analysis, and what imaging modalities do they support?

Medviso AB offers clinical software solutions like Segment CMR for quantitative analysis of cardiac magnetic resonance (CMR) images, and Segment CT Research for cardiac computed tomography (CT) analysis. These solutions incorporate AI algorithms to streamline analysis of various cardiac functions, including LV, RV, LA, and RA.

How do Medviso AB's solutions, particularly with AI algorithms, optimize workflow for physicians and healthcare administrators?

Medviso's software, such as Segment CMR and the AI AutoMate module, is designed to optimize workflow by providing AI-powered automated segmentation and analysis of cardiac images. This streamlines the entire CMR analysis process, from sorting and loading DICOM data to performing comprehensive cardiac assessments, ultimately saving time and enhancing efficiency in clinical routine.

What specific capabilities does Medviso AB offer for cardiac strain analysis, and what imaging modalities are supported?

Medviso AB provides a comprehensive Strain Analysis Module, integrated into Segment CMR, which is the only clinically approved software on the market for cardiac strain analysis including both feature tracking and tagging analysis in one package. This module is applicable to both Cardiac MR (cine and tagging) and Cardiac CT images, allowing for global and segmental strain quantification in all four heart chambers.

Can Medviso AB assist with 3D modeling and 3D printing for patient-specific applications, and what are the benefits?

Yes, Medviso AB offers Segment 3DPrint, a complete software solution that facilitates the creation of high-quality, ready-to-print 3D models directly from DICOM images. They also provide a 3D Modeling Service where experts can perform segmentation and deliver digital or printed models, which can help reduce surgical time, improve patient satisfaction through better procedure explanation, and support personalized patient care.

What regulatory approvals do Medviso AB's medical software solutions hold, and do they offer regulatory consulting?

Medviso AB's clinical software solutions, including Segment CMR and Segment 3DPrint, are CE-marked under the Medical Device Regulation (EU) 2017/745 (MDR) and have FDA 510(k) clearance. The Strain analysis module is also included in these regulatory approvals. Medviso also offers comprehensive regulatory consulting services, from education to complete packages for CE-marking and FDA 510(k) applications.

What kind of support and pricing models does Medviso AB offer for its software solutions?

Medviso offers customer support via email and through a dedicated 'Support Request' feature within their software, along with user manuals and tutorial videos. For pricing, they offer flexible license terms, including a 'Pay Per Case' option for clinical software like Segment CMR, which can be advantageous for sites with lower scanning volumes.

What is Medviso AB's company background and stability, and how do they engage with the research community?

Established in 2007 and remaining family-owned, Medviso AB specializes in medical imaging analysis and workflow optimization, with a strong focus on cardiovascular applications. They actively support the research community by providing their Segment software freely for research purposes and collaborate closely with institutions like Lund Cardiac MR Group and Skåne University Hospital to develop and validate their tools.

Related Companies

Suggest an Edit → | Report an issue